321 related articles for article (PubMed ID: 30139340)
1. Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).
Mohkam K; Rayar M; Adam JP; Muscari F; Rode A; Merle P; Pradat P; Bauler S; Delfour I; Chiche L; Ducerf C; Boudjema K; Lesurtel M; Laurent C; Mabrut JY
BMC Cancer; 2018 Aug; 18(1):844. PubMed ID: 30139340
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic Liver Surgery: What Are the Advantages in Patients with Cirrhosis and Portal Hypertension? Systematic Review and Meta-Analysis with Personal Experience.
Coletta D; De Padua C; Parrino C; De Peppo V; Oddi A; Frigieri C; Grazi GL
J Laparoendosc Adv Surg Tech A; 2020 Oct; 30(10):1054-1065. PubMed ID: 32707003
[No Abstract] [Full Text] [Related]
3. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis.
Kanazawa A; Tsukamoto T; Shimizu S; Kodai S; Yamazoe S; Yamamoto S; Kubo S
Surg Endosc; 2013 Jul; 27(7):2592-7. PubMed ID: 23392977
[TBL] [Abstract][Full Text] [Related]
4. Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study.
Fuster J; Llovet JM; Garcia-Valdecasas JC; Grande L; Fondevila C; Vilana R; Palacin J; Tabet J; Ferrer J; Bruix J; Visa J
Hepatogastroenterology; 2004; 51(56):536-40. PubMed ID: 15086197
[TBL] [Abstract][Full Text] [Related]
5. Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma.
Rajakannu M; Cherqui D; Ciacio O; Golse N; Pittau G; Allard MA; Antonini TM; Coilly A; Sa Cunha A; Castaing D; Samuel D; Guettier C; Adam R; Vibert E
Surgery; 2017 Oct; 162(4):766-774. PubMed ID: 28711320
[TBL] [Abstract][Full Text] [Related]
6. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma.
Ziegler TR
JPEN J Parenter Enteral Nutr; 1996; 20(1):91-2. PubMed ID: 8788271
[TBL] [Abstract][Full Text] [Related]
7. [Initial comparison of regional ischemic preconditioning and hemi-hepatic vascular inflow occlusion in resection of hepatocellular carcinoma].
Feng L; Wang L; Rong W; Wu F; Yu W; An S; Liu F; Tian F; Wu J
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):186-9. PubMed ID: 25975786
[TBL] [Abstract][Full Text] [Related]
8. Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial.
Lee KF; Wong J; Cheung SYS; Chong CCN; Hui JWY; Leung VYF; Yu SCH; Lai PBS
World J Surg; 2018 Oct; 42(10):3302-3311. PubMed ID: 29696328
[TBL] [Abstract][Full Text] [Related]
9. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.
Reddy MS; Kaliamoorthy I; Rajakumar A; Malleeshwaran S; Appuswamy E; Lakshmi S; Varghese J; Rela M
Liver Transpl; 2017 Aug; 23(8):1007-1014. PubMed ID: 28294557
[TBL] [Abstract][Full Text] [Related]
10. Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.
Itoh S; Uchiyama H; Ikeda Y; Morita K; Harada N; Sugimachi K; Kawanaka H; Korenaga D; Yoshizumi T; Takenaka K; Maehara Y
Anticancer Res; 2017 Mar; 37(3):1381-1385. PubMed ID: 28314307
[TBL] [Abstract][Full Text] [Related]
11. Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial.
Xu Y; Chen J; Wang H; Zheng H; Feng D; Zhang A; Leng J; Duan W; Yang Z; Chen M; Shi X; Cai S; Ji W; Jiang K; Zhang W; Chen Y; Gu W; Dong J; Lu S
Trials; 2016 Oct; 17(1):492. PubMed ID: 27724929
[TBL] [Abstract][Full Text] [Related]
12. Preoperative dexamethasone administration in hepatectomy of 25-min intermittent Pringle's maneuver for hepatocellular carcinoma: protocol for a randomized controlled trial.
Huang Y; Xu L; Wang N; Pu X; Wang W; Wen T; Xu M; Jiang L
Trials; 2023 Nov; 24(1):774. PubMed ID: 38037035
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Bruix J; Takayama T; Mazzaferro V; Chau GY; Yang J; Kudo M; Cai J; Poon RT; Han KH; Tak WY; Lee HC; Song T; Roayaie S; Bolondi L; Lee KS; Makuuchi M; Souza F; Berre MA; Meinhardt G; Llovet JM;
Lancet Oncol; 2015 Oct; 16(13):1344-54. PubMed ID: 26361969
[TBL] [Abstract][Full Text] [Related]
14. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection.
Hsieh CB; Yu CY; Tzao C; Chu HC; Chen TW; Hsieh HF; Liu YC; Yu JC
Eur J Surg Oncol; 2006 Feb; 32(1):72-6. PubMed ID: 16246517
[TBL] [Abstract][Full Text] [Related]
16. Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial.
Ciacio O; Voron T; Pittau G; Lewin M; Vibert E; Adam R; Sa Cunha A; Cherqui D; Schielke A; Soubrane O; Scatton O; Salloum C; Azoulay D; Benoist S; Goyer P; Vaillant JC; Hannoun L; Boleslawski E; Agostini H; Samuel D; Castaing D
BMC Cancer; 2014 Dec; 14():980. PubMed ID: 25523036
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of three types of anatomical vascular occlusion method in hepatectomy for liver neoplasms].
Wang LM; Rong WQ; Wu JX; Liu LG; Wu F; Xu Q; Yu WB; An SL; Liu FQ
Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1730-3. PubMed ID: 24124681
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure].
Lao XM; Zhang YQ; Lin XJ; Guo RP; Chen MS; Yuan YF; Li JQ; Li GH
Ai Zheng; 2005 Mar; 24(3):337-40. PubMed ID: 15757537
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Postoperative Ascites in Patients Undergoing Liver Resection for Hepatocellular Carcinoma.
Yoshikawa T; Nomi T; Hokuto D; Yasuda S; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
World J Surg; 2017 Aug; 41(8):2095-2100. PubMed ID: 28332060
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking increases risk of early morbidity after hepatic resection in patients with hepatocellular carcinoma.
Lv Y; Liu C; Wei T; Zhang JF; Liu XM; Zhang XF
Eur J Surg Oncol; 2015 Apr; 41(4):513-9. PubMed ID: 25656703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
